Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Clinical trial NCT02231749 · COMPLETED
Trial details
- NCT number
- NCT02231749
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-16
- Primary completion
- 2017-06-26
- Enrollment
- 1096
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.